Company Update CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release BSE India Please find the attached Press Release on USFDA approval for Ofloxacin Ophthalmic Solution ANDA.